It was demonstrated that CTGF is overexpressed in malignant melanoma, as well as in activated fibroblasts present within the tumor niche, while the loss of CTGF expression led to a decrease in fibroblast activation level [80,81]. The gene discussed is CCN2; the disease is neoplasm.